Work

Clinical and translational studies of depsipeptide (romidepsin), a histone deacetylase (HDAC) inhibitor, in patients with squamous cell carcinoma of the head and neck (SCCHN): New York Cancer Consortium Trial P6335

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.6065

Authors: M. Haigentz, M. Kim, C. Sarta, R. S. Keresztes, R. V. Smith, T. J. Belbin, J. M. Mariadason, J. M. Greally, G. I. Shapiro, R. I. Haddad

Institutions: Albert Einstein College of Medicine, Cornell University, Dana-Farber Cancer Institute

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601537845

Cites:

Cited by: 3

Related to: 10